Cargando…
Activity tracking devices in sarcoidosis
INTRODUCTION: Activity tracker device usage can help analyze the impact of disease state and therapy on patients in clinical practice. Factors such as age, race, and gender may contribute to difficulties with using such technology. OBJECTIVE: We evaluated the effect of age, race, and gender on the u...
Autores principales: | Klein, Rebecca A., Judson, Marc A., Barkes, Riana, Maier, Lisa A., Zeigler, Joyce, Culver, Daniel A., Sweiss, Nadera, Chen, Edward S., Hamzeh, Nabeel, Grutters, Jan C., Valeyre, Dominique, Singh, Noopur, Spitzer, Virginia, Shivas, Tricha, Baughman, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099655/ https://www.ncbi.nlm.nih.gov/pubmed/36975058 http://dx.doi.org/10.36141/svdld.v40i1.12395 |
Ejemplares similares
-
COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
por: Manansala, Michael, et al.
Publicado: (2021) -
Response
por: Sweiss, Nadera J., et al.
Publicado: (2021) -
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
por: Rahaghi, Franck F., et al.
Publicado: (2020) -
Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial
por: Baughman, Robert P, et al.
Publicado: (2021) -
Autoantibody profile in sarcoidosis, analysis from the GRADS sarcoidosis cohort
por: Khassawneh, Basheer, et al.
Publicado: (2022)